Powerful Medical Receives €40 Million IPCEI Grant — read the full story

Powerful Medical
19. November 2025
3 min to read

Artificial Intelligence Versus Human Expertise: ECG-Based Detection of Occlusive Myocardial Infarction After Cardiac Arrest

Overview

This single-centre study tested whether AI-based ECG analysis can detect occlusive myocardial infarction (OMI) after cardiac arrest using post-ROSC ECGs from 97 patients with subsequent coronary angiography. A dedicated deep neural network (Queen of Hearts, QoH) achieved the highest discrimination for acute coronary occlusion (AUC 0.85) and OMI (AUC 0.75), outperforming human experts, with a more balanced trade-off between sensitivity and specificity. In contrast, two large language model–based chatbots (ChatGPT and a GPT-based EKG Analyst) showed near-perfect sensitivity but almost no specificity, labelling nearly all ECGs as OMI and thus providing no meaningful diagnostic discrimination. These findings suggest that specialized ECG-trained AI, such as QoH, may serve as a useful adjunct in post-resuscitation decision-making. In contrast, general-purpose LLMs are currently unsuitable for critical ECG diagnosis.

Published in: Resuscitation
Published on: 19 November 2025

Background

Accurate electrocardiogram (ECG) interpretation after cardiac arrest is essential for identifying occlusive myocardial infarction (OMI), but post-resuscitation artifacts make this challenging. While artificial intelligence (AI) offers promising support, its diagnostic performance in this critical setting remains uncertain.

Methods

This single-centre study included 97 adult patients resuscitated from cardiac arrest (CA). Post-return of spontaneous circulation (ROSC), ECGs were evaluated by four methods: human experts (HE), a validated deep neural network (Queen of Hearts [QoH]), and two large language model (LLM)–based AI chatbots (AI-CB) – ChatGPT and EKG Analyst. The primary outcome was the AUROC for the presence and probability of OMI and acute coronary occlusion (ACO), determined by coronary angiography.

Results

For ACO (TIMI 0), QoH yielded the highest AUROC (0.846 [0.752–0.939]), followed by HE (0.735 [0.622 – 0.848]). Both AI-CB resulted in the lowest AUROC (ChatGPT: 0.456 [0.319 – 0.592]; EKG Analyst: 0.474 [0.346 – 0.603]. For OMI (TIMI 0-2 or TIMI 3 + peak-troponin), QoH again achieved the highest AUROC (0.745 [0.647 – 0.843]), followed by HE (0.635 [0.515 – 0.755]), AI-CB were lowest again (ChatGPT: 0.495 [0.376 – 0.614]; EKG Analyst: 0.626 [0.508 – 0.743]. Threshold-dependent performance metrics revealed high sensitivity (ACO: 100%; OMI: 98.36%) for both AI-CB, at the cost of minimal specificity. QoH and HE showed more even distributions of sensitivity/specificity.

Conclusion

QoH, despite operating without awareness of the CA-setting and thus likely at a relative disadvantage, and HE showed robust diagnostic accuracy. Due to undifferentiated overdiagnosis, general LLMs remain unsuitable for ECG interpretation. Domain-specific tools, such as QoH, may offer complementary value.

Artificial Intelligence Versus Human Expertise: ECG-Based Detection of Occlusive Myocardial Infarction After Cardiac Arrest
Authors: Claudio Silwanis, Johannes Eder, Alexander Fellner, Alexander Nahler, Max Groche, Hermann Blessberger, Jörg Kellermair, Anna Neunteufel, Maximilian Huss, Julian Maier, Clemens Steinwender, Thomas Lambert

Author-Logo_PM
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.

About PMcardio

PMcardio is a CE-certified AI that reads ECGs and offers a complex assessment of 49 cardiac conditions. Clinically validated in 15+ studies and trusted by over 100,000 clinicians, it delivers rapid, expert‑level interpretations, empowering emergency physicians, GPs, nurses, paramedics, and cardiologists to act with confidence at the point of care. Available for Individuals and Organizations.

About Powerful Medical

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Relevant Publications

Chest Pain With Subtle But Lifesaving ECG Findings

This study presents a clinical case highlighting the diagnostic value of hyperacute T waves on electrocardiogram (ECG) for early detection of acute coronary occlusion. A 54-year-old woman presented with classic ischemic symptoms, yet her initial ECG was interpreted as normal by both automated analysis and clinician review. Closer inspection revealed subtle hyperacute T waves in the anterior leads, consistent with acute occlusion of the left anterior descending (LAD) artery. The case underscores how reliance on traditional ST-segment elevation criteria alone may delay recognition of life-threatening myocardial infarction.

AI-Enhanced Electrocardiogram for Detection of Occlusive Myocardial Infarction in High-Risk Non–ST-Segment Elevation Acute Coronary Syndrome

This study evaluates an AI-enhanced ECG model for detecting occlusive myocardial infarction (OMI) in patients with high-risk non–ST-segment elevation acute coronary syndrome, using angiography as the reference. The model improved rule-in accuracy with high specificity (78%) and reduced false-positive cath lab activations compared with standard care, while rule-out sensitivity remained limited on the initial ECG. Serial ECG analysis improved detection, supporting the use of AI as a triage aid alongside clinical judgment rather than a standalone diagnostic tool.

Join over 100,000 healthcare professionals who are already taking advantage of AI

Heart Attacks are #1 cause of death world-wide and killing about 12 milions people a year.

Clinical Definition of Problem

Contrary to popular belief, a heart attacks isn’t a blockage inside of the heart. A heart attack is a blockage of the coronary arteries supplying the heart muscle with oxygenated blood.

So let’s assume you get a blood clot here — it blocks the blood flow downstream, meaning the heart muscle doesn’t get oxygenated blood and heart tissue downstream starts to die.

Clinical Solution​

The way to fix it is relatively simple – doctors put in a stent that opens up the artery and renews blood flow. The latest clinical practice guidelines recommend that this “stenting” happens within 90 minutes from symptom onset.

If you don’t, even if you put in the stent in later, the heart tissue downstream has already been permanently damaged, which reduces the heart’s ability to pump blood. This is the leading cause of heart failure and increases 1-year mortality by two-fold.

Time is muscle.

You have just 90 minutes to diagnose the patient, bring them to the hospital and put in the stent, otherwise there is permanent damage. So problem is, that 1 in 2 heart attacks get initially misdiagnosed at the first point of contact.

Discover the future of medical work with us.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.